This study will evaluate the safety, tolerability and efficacy of a new antifungal agent as compared to fluconazole in the treatment of esophageal candidiasis. Patients will be stratified by neutrophil count and randomized to either the study drug or fluconazole.
Showing the most recent 10 out of 600 publications